A frozen leap forward for age-related macular degeneration stem cell-based therapy
Fitbit user data show slight increase in sleep duration in US during COVID-19 pandemic
14 June 2021‘Ice’ flavored e-cig use may be linked to nicotine dependence among the young
14 June 2021A frozen leap forward for age-related macular degeneration stem cell-based therapy
Scientists at UC Santa Barbara, University of Southern California (USC), and the biotechnology company Regenerative Patch Technologies LLC (RPT) have reported new methodology for preservation of RPT’s stem cell-based therapy for age-related macular degeneration (AMD).
